Stock listing

NASDAQ:GH Guardant Health, Inc. Stock

Home listing (NASDAQ) of Guardant Health, Inc.

Follow Guardant Health, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:GH

$158.60 USD -7.28 (-4.4%)

Close on Oct 16, 2026

Since Jul 6, 2026 -6.1% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$157.44 – $168.47 USDOct 16, 2026
Volume
1.98M sharesOct 16, 2026
Market value
$21.28B USDAt the close on Oct 16, 2026 · price × 134.2M shares outstanding
Guardant Health, Inc. logo
Ticker
NASDAQ:GH
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Guardant Health (NASDAQ:GH) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 4:30 PM ET

    Watch Transcript

  • Guardant Health (NASDAQ:GH) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 4:30 PM ET

    Watch Transcript

  • Guardant Health (NASDAQ:GH) Q3 2025 Earnings Call

    Wed, Oct 29, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests

Oct 15, 2026

Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer

Oct 8, 2026

Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026

Oct 8, 2026

Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma

Oct 5, 2026

Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening

Sep 14, 2026

Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer

Sep 9, 2026

Business Insider Names Guardant Health One of America's Most Innovative Businesses

Sep 8, 2026

Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026

Sep 8, 2026

Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer

Sep 4, 2026

Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening

Sep 1, 2026

All Guardant Health, Inc. news

Decks

Guardant Health, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
64 in the last 12 months · 291 in all · newest Oct 15, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Jul 30, 2026
Decks
35 decks · latest Jul 30, 2026

Where Guardant Health, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:GH · Home listing · This pageNASDAQUnited StatesUSD
gettex:5GHgettexGermanyEUR
LS Exchange:A2N5RYLS ExchangeGermanyEUR
Lang & Schwarz:A2N5RYLang & SchwarzGermanyEUR
Tradegate:5GHTradegateGermanyEUR
BX Swiss:GHBX SwissSwitzerlandCHF
BMV:GHBMVMexicoMXN
BIVA:GHBIVAMexicoMXN
BOATS:GHBOATSUnited StatesUSD
Milan:1GHMilanItalyEUR
Frankfurt:5GHFrankfurtGermanyEUR
Munich:5GHMunichGermanyEUR
Dusseldorf:5GHDusseldorfGermanyEUR
Hamburg:5GHHamburgGermanyEUR
Stuttgart:5GHStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Guardant Health, Inc.